Biomarkers Assay Group - Technologies
Several platforms/technologies are available among the NPRC laboratories encompassing traditional to state-of-the-art methodologies. These include radiommunoassays (RIA) working with both alpha and beta particles, enzyme-linked immunoabsorbent assays (ELISA), chromatography separations, automated clinical platforms, high performance liquid chromatography (HPLC) linked with UV or electrochemical detection, and tandem tiple quadrupole mass spectrometry (LC/MS/MS).
This list of technologies is not all inclusive. If you do not see the technology you are looking for, please contact the NPRCs and ask for a consultation.
Click center for contact information.
 Additional detail exists |
|
Assay is supported |
 Category is fully expanded |
Assay is not supported | |
| No arrow = No further detail | |
Automatic Clinical Platform
Roche Cobas e411 CLA: Siemen's Centaur BioassaysCelite ChromatographyEnzyme-linked immunosorbent assay (ELISA)Flow CytometryHigh Performance Liquid Chromatography (HPLC); UVD, ECDShimadzu Nexera-LCMS-8050 Immunoradiometric Assay (IRMA)Liquid Chromatography, Mass Spectrometry and QTRAP LC/MS/MSAB Sciex QTrap 650AB, Sciex QTrap 6500 Thermo Fisher Q-Trap Mass Spectrometer SpectraMax i3x Multi-Mode Detection Platform Tecan Infinite M200 Pro DRG Hybrid XL LuminexLuminex LX-200 NanostringRadioimmunoassay (RIA)Sephadex LH-20